Developing small molecule antagonists against AM2 receptor for the treatment of pancreatic cancer
Pancreatic cancer is the 11th most common cancer type in the UK. The survival rates are among the lowest in the UK which is directly reflected by its mortality rates that keep raising. Existing therapies include surgical removal and cytotoxic chemotherapeutic cocktails which have minimal improvement...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Sheffield
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.755208 |